Clinical Trials Browser

Phase 2 × Pancreatic Adenocarcinoma × Cetuximab × Clear all

NCT02736578 2019-06-25

Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery

Phase 2 Terminated

8 enrolled 16 charts

Gastrointestinal

Pancreatic Adenocarcinoma